Hope. Now within reach. Aiming to reach a billion patients worldwide with affordable, lifesaving medicines. Meeting unmet patient needs. Our novel biologics address unmet medical needs across the world. Research saves lives. We are accelerating drug innovation and development for companies globally. A Century of Insulins Marking 100 years of the pivotal medical breakthrough that is saving millions of people with diabetes. Let's fight the COVID-19 outbreak DCGI gives NOD for Restricted Emergency Use of Itolizumab in Moderate to Severe COVID-19 Patients. The 10-cent answer to Diabetes. At 10 cents a day our insulin
is a game changer in the developing world.
WHO WE ARE
Driven by purpose.
We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines.